Is srpt a buy
Witryna1 dzień temu · Sarepta Therapeutics (SRPT) shares lost Thursday after a report indicated that FDA staff had initially opposed the company's gene therapy candidate SRP-9001. Read more here. Witryna1 dzień temu · SRPT Price Action: Sarepta has a 52-week high of $159.83 and a 52-week low of $61.30. The stock was down 10.2% at $123.69 at time of publication, according to Benzinga Pro . Photo: felixioncool ...
Is srpt a buy
Did you know?
Witryna21 kwi 2024 · SRPT stock is down 20% off the March 2024 bottom compared to the S&P which has moved 85%. SRPT stock has significantly underperformed the broader markets, primarily due to a development around its ... Witryna11 kwi 2024 · The Global X SuperDividend REIT ETF price gained 0.700% on the last trading day (Thursday, 6th Apr 2024), rising from $21.42 to $21.57. During the last trading day the ETF fluctuated 1.19% from a day low at $21.34 to a day high of $21.59. The price has risen in 7 of the last 10 days and is up by 5.63% over the past 2 weeks.
Witryna1 cze 2024 · Sarepta Therapeutics Inc (NASDAQ:SRPT) has earned a consensus rating of “Buy” from the twenty-seven brokerages that are currently covering the company, Marketbeat Ratings reports.One analyst has rated the stock with a sell rating, one has assigned a hold rating and twenty-five have given a buy rating to the company. Witryna8 sty 2024 · Overall, with 15 analyst reviews on record, split into 9 Buys, 5 Holds, and single Sell, SRPT gets a Moderate Buy consensus rating. Meanwhile, the average price target clocks in at $153.33 and ...
Witryna20 gru 2024 · Do Hedge Funds Think SRPT Is A Good Stock To Buy Now? Heading into the fourth quarter of 2024, a total of 35 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of ... WitrynaSarepta Therapeutics Inc. is leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with raredisease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type ...
Witryna19 mar 2024 · Shares of SRPT opened at $122.69 on Friday. The company has a debt-to-equity ratio of 4.01, a quick ratio of 3.80 and a current ratio of 4.13. Sarepta Therapeutics has a fifty-two week low of $61. ...
WitrynaSRPT: $100: BUY CALL: 2024-03-19: $11.27: $98.24: 986: 95: Realtime ROI Track Record Bot Info Leaderboard: Week, Month, All Exit this position *Recorded after market close, will be recorded at the next market open if the premium is within 10% margin. My owner is monitoring these posts, reply with feedback! You can now track … family dollar nyssa oregonWitryna17 mar 2024 · The Sarepta Therapeutics (SRPT) option chain shows the call options quotes to the left side of the table and the put options quotes on the right side. The bid is where the current market is indicating a desire to buy at the specified price, while the ask is where the market is indicating a desire to sell at the specified price. family dollar oak hill wvWitryna12 kwi 2024 · Get a real-time Sarepta Therapeutics, Inc. (SRPT) stock price quote with breaking news, financials, statistics, charts and more. ... According to 28 analysts, the average rating for SRPT stock is "Buy." The 12-month stock price forecast is $172.28, which is an increase of 25.13% from the latest price. Price Target. $172.28 family dollar oak forest ilWitryna20 mar 2024 · Sarepta Therapeutics Inc. (NASDAQ: SRPT) stock closed at 131.38 per share at the end of the most recent trading day (a 7.08 % change compared to the prior day closing price) with a volume of 2.63M shares and market capitalization of 11.56B.Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The … family dollar oak hill ohioWitryna3 mar 2024 · We see that SRPT’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy. family dollar nw 39th okcWitryna23 lut 2024 · In a report released on February 22, Brian Abrahams from RBC Capital maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price target of $195.00.The company’s ... family dollar nylonsWitryna22 lut 2024 · Buy or sell stock? Will SRPT stock price go up? What are analysts’ forecasts for SRPT stock? Forecst.com predicts future values using technical analysis of a large number of analytical parameters. SRPT stock returns are also predicted based on historical data. According to our research, SRPT stock is a bad long-term investment. family dollar oakland maine